Clinical trials rarely stall because of science alone. More often, they slow due to recruitment challenges—particularly in rare and clinically complex conditions. When that happens, knowing that eligible patients exist is not enough. Sponsors need to locate eligible...
Real-world evidence is critical for understanding how therapies perform beyond controlled clinical trials. Yet many life sciences organizations rely on fragmented proprietary data that lack the longitudinal clinical context needed to support regulatory, payer, and...
Clinical trials remain one of the most resource-intensive stages of drug development. Slow enrollment, protocol amendments, zero-enrollment sites, and incomplete real-world evidence can delay timelines and increase cost—ultimately slowing access to life-changing...
Today, we are excited to introduce Truveta Live Link, a breakthrough solution that transforms how life science organizations generate real-world evidence. Truveta Live Link unites a life sciences organization’s proprietary data and continuously updated real-world...
Today, Truveta was featured as #1 on LinkedIn’s Top Startups in Seattle for 2025 list. The ranking highlights ten growing start-up companies in the Seattle area. Last year, Truveta was ranked #3 on the inaugural Seattle list. Earlier this month, Truveta was also...
